The FDA has approved expanded MRI labeling for Abbott’s dorsal root ganglion stimulation therapy, which allows those with complex regional pain syndrome to receive full-body MRI scans while ...

We evaluated the effects of chronic hyperglycemia on L5 dorsal root ganglion (DRG) neurons using immunohistochemical and electrophysiologic techniques for evidence of oxidative injury ...

New Rochelle, NY, September 2, 2020—A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.

"We believe our data demonstrate that neurodegeneration in the dorsal root ganglion is a critical facet of the disease—which should really force us to think about the disease in a new and urgent ...

A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology. There were no clinical effects. The study is ...

Troy Nesbit, MD, of Rapid City, S.D.-based West River Anesthesia is the state’s only anesthesiologist trained to perform the dorsal root ganglion procedure, according to local news station KEVN Black ...

A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology. There were no clinical effects.

By implanting a spinal cord stimulator to stimulate the dorsal root ganglion (DRG) in the patient’s spine, they were able to block pain sensations originating from the damaged nerve.

The dorsal root ganglion – or DRG – is a cluster of nerve cells found along the spine that control pain signals from specific areas of the body, including the pelvis, groin, hip, knee, ankle and foot.